Japan Tobacco Inc.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 12 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Top Mutual Funds / ETFs
Updated 2026/01/11Major Holders
Updated 2026/01/11| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
Goldman Sachs TRT II-Goldman Sachs GQG Part. Intl Opportunities Fd.
|
24.6M | +6.59% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
15.9M | +0.31% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
10.1M | +2.63% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
8.3M | +0.96% | |
|
Fidelity Concord Street Trust-Fidelity International Index Fund
|
4.2M | -0.17% | |
|
iShares, Inc.-iShares MSCI Japan ETF
|
4.2M | +0.80% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
907.7K | +2.18% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥234 | +20.6% |
| 2024 | ¥194 | 0.0% |
| 2023 | ¥194 | +3.2% |
| 2022 | ¥188 | +34.3% |
| 2021 | ¥140 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,324,838M | ¥2,657,832M | ¥2,841,077M | ¥3,149,759M |
| Gross Profit | ¥1,367,976M | ¥1,566,843M | ¥1,615,103M | ¥1,742,297M |
| Operating Income | ¥495,024M | ¥645,567M | ¥664,078M | ¥310,575M |
| Pretax Income | ¥518,035M | ¥684,722M | ¥716,823M | ¥392,964M |
| Net Income | ¥338,490M | ¥442,716M | ¥482,289M | ¥179,240M |
| EPS | ¥190.68 | ¥249.36 | ¥271.63 | ¥100.94 |
| Operating Margin | 21.29% | 24.29% | 23.37% | 9.86% |
| Balance Sheet | ||||
| Total Assets | ¥5,774,209M | ¥6,548,078M | ¥7,282,097M | ¥8,370,732M |
| Total Equity | ¥2,809,258M | ¥3,540,435M | ¥3,830,156M | ¥3,766,623M |
| Total Liabilities | ¥2,964,951M | ¥3,007,643M | ¥3,451,941M | ¥4,604,109M |
| Cash | ¥721,731M | ¥866,885M | ¥1,040,206M | ¥1,084,567M |
| Interest-bearing Debt | ¥918,622M | ¥958,311M | ¥1,142,259M | ¥1,726,788M |
| Equity Ratio | 48.65% | 54.07% | 52.60% | 45.00% |
| D/E Ratio | 0.33 | 0.27 | 0.30 | 0.46 |
| Cash Flow | ||||
| Operating CF | ¥598,909M | ¥483,799M | ¥566,317M | ¥630,011M |
| Investing CF | -¥97,499M | -¥101,822M | -¥125,432M | -¥439,766M |
| Financing CF | -¥353,138M | -¥306,176M | -¥270,500M | -¥94,906M |
| Free CF | ¥495,991M | ¥384,391M | ¥449,749M | ¥479,644M |
| Efficiency | ||||
| ROE | 12.05% | 12.50% | 12.59% | 4.76% |
| ROA | 5.86% | 6.76% | 6.62% | 2.14% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 2914
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥5,744
Rating Score: 2.25 (Based on 12 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products comprising frozen udon noodles, packed rice, and frozen okonomiyaki; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
